Literature DB >> 20954287

Up-regulation of PIK3CA promotes metastasis in gastric carcinoma.

Ji-Fang Liu1, Xin-Ke Zhou, Jin-Hui Chen, Gao Yi, He-Ge Chen, Ming-Chen Ba, Sheng-Qu Lin, Yan-Chao Qi.   

Abstract

AIM: To explore expressions of PIK3CA in the progression of gastric cancer from primary to metastasis and its effects on activation of phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
METHODS: mRNA and protein levels of PIK3CA were assessed, respectively, by real-time quantitative polymerase chain reaction and immunohistochemistry in specimens of normal gastric mucosa, primary foci and lymph node and distant metastasis of gastric cancer. Akt and phosphorylated Akt protein were also examined by Western blotting in these tissues, in order to analyze the effect of PIK3CA expression level changes on the activation of PI3K/Akt signaling pathway.
RESULTS: PIK3CA mRNA in lymph node metastasis were approximately 5 and 2 folds higher, respectively, than that in the corresponding normal gastric mucosa and primary gastric cancer tissues (P < 0.05), while no statistical significance was found compared with distant metastasis. Immunohistochemically, PIK3CA protein expression was discovered in 7 (35%) specimens of 20 primary foci vs 10 (67%) of 15 of lymph node metastasis or 11 (61%) of 18 of distant metastasis (35% vs 67%, P = 0.015; 35% vs 61%, P = 0.044). With the increased level of PIK3CA expression, the total Akt protein expression remained almost unchanged, but p-Akt protein was upregulated markedly.
CONCLUSION: Increased expression of PIK3CA is expected to be a promising indicator of metastasis in gastric cancer. Up-regulation of PIK3CA may promote the metastasis of gastric cancer through aberrant activation of PI3K/Akt signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20954287      PMCID: PMC2957609          DOI: 10.3748/wjg.v16.i39.4986

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

Review 3.  The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB.

Authors:  E S Kandel; N Hay
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

4.  Molecular cloning, cDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinase p110 alpha (PIK3CA) gene.

Authors:  S Volinia; I Hiles; E Ormondroyd; D Nizetic; R Antonacci; M Rocchi; M D Waterfield
Journal:  Genomics       Date:  1994-12       Impact factor: 5.736

5.  Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma.

Authors:  Joachim Woenckhaus; Klaus Steger; Eva Werner; Irina Fenic; Ulrike Gamerdinger; Thomas Dreyer; Ulrich Stahl
Journal:  J Pathol       Date:  2002-11       Impact factor: 7.996

6.  Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.

Authors:  Atsuko Hara; Isao Okayasu
Journal:  Acta Neuropathol       Date:  2004-04-16       Impact factor: 17.088

7.  The PIK3CA gene is mutated with high frequency in human breast cancers.

Authors:  Kurtis E Bachman; Pedram Argani; Yardena Samuels; Natalie Silliman; Janine Ptak; Steve Szabo; Hiroyuki Konishi; Bedri Karakas; Brian G Blair; Clarence Lin; Brock A Peters; Victor E Velculescu; Ben Ho Park
Journal:  Cancer Biol Ther       Date:  2004-08-26       Impact factor: 4.742

8.  Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer.

Authors:  Zeenath Jehan; Prashant Bavi; Mehar Sultana; Jehad Abubaker; Rong Bu; Azhar Hussain; Ghazi Alsbeih; Nasser Al-Sanea; Alaa Abduljabbar; Luai H Ashari; Samar Alhomoud; Fouad Al-Dayel; Shahab Uddin; Khawla S Al-Kuraya
Journal:  J Pathol       Date:  2009-11       Impact factor: 7.996

9.  Oncogenic mutations of PIK3CA in human cancers.

Authors:  Yardena Samuels; Victor E Velculescu
Journal:  Cell Cycle       Date:  2004-10-12       Impact factor: 4.534

10.  PIK3CA is implicated as an oncogene in ovarian cancer.

Authors:  L Shayesteh; Y Lu; W L Kuo; R Baldocchi; T Godfrey; C Collins; D Pinkel; B Powell; G B Mills; J W Gray
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

View more
  31 in total

1.  RNAi knockdown of PIK3CA preferentially inhibits invasion of mutant PIK3CA cells.

Authors:  Xin-Ke Zhou; Sheng-Song Tang; Gao Yi; Min Hou; Jin-Hui Chen; Bo Yang; Ji-Fang Liu; Zhi-Min He
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

2.  Phosphoinositide-3-kinase, catalytic, alpha polypeptide RNA interference inhibits growth of colon cancer cell SW948.

Authors:  Wen-Sheng Huang; Tian-Bao Wang; Yao He; Yu-Jun Chen; Shi-Long Zhong; Min Tan
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

3.  The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance.

Authors:  Oscar Tapia; Ismael Riquelme; Pamela Leal; Alejandra Sandoval; Susana Aedo; Helga Weber; Pablo Letelier; Enrique Bellolio; Miguel Villaseca; Patricia Garcia; Juan Carlos Roa
Journal:  Virchows Arch       Date:  2014-05-21       Impact factor: 4.064

4.  The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines.

Authors:  Ismael Riquelme; Oscar Tapia; Jaime A Espinoza; Pamela Leal; Kurt Buchegger; Alejandra Sandoval; Carolina Bizama; Juan Carlos Araya; Richard M Peek; Juan Carlos Roa
Journal:  Pathol Oncol Res       Date:  2016-05-07       Impact factor: 3.201

Review 5.  Glucose metabolism in gastric cancer: The cutting-edge.

Authors:  Lian-Wen Yuan; Hiroharu Yamashita; Yasuyuki Seto
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 6.  The potential role of leptin in tumor invasion and metastasis.

Authors:  Amitabha Ray; Margot P Cleary
Journal:  Cytokine Growth Factor Rev       Date:  2017-11-11       Impact factor: 7.638

7.  Upregulation of microRNA-31 targeting integrin α5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells.

Authors:  Xue-Bin Zhang; Lei Song; Hong-Juan Wen; Xiao-Xue Bai; Zhen-Juan Li; Lian-Jun Ma
Journal:  Tumour Biol       Date:  2016-01-04

8.  Multiple genetic alterations within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinoma.

Authors:  Carmela De Marco; Nicola Rinaldo; Paola Bruni; Carmine Malzoni; Fulvio Zullo; Fernanda Fabiani; Simona Losito; Marianna Scrima; Federica Zito Marino; Renato Franco; Alfina Quintiero; Valter Agosti; Giuseppe Viglietto
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

9.  Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinase.

Authors:  Marianna Scrima; Carmela De Marco; Fernanda Fabiani; Renato Franco; Giuseppe Pirozzi; Gaetano Rocco; Maria Ravo; Alessandro Weisz; Pietro Zoppoli; Michele Ceccarelli; Gerardo Botti; Donatella Malanga; Giuseppe Viglietto
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

10.  PI3K/Akt signalling is required for the attachment and spreading, and growth in vivo of metastatic scirrhous gastric carcinoma.

Authors:  T Matsuoka; M Yashiro; N Nishioka; K Hirakawa; K Olden; J D Roberts
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.